Alfredo Colombo, Concetta Maria Porretto
This article summarizes the progress of treatment in advanced hepatocellular carcinoma, biliary tract cancer, and pancreatic cancer in 2023, including chemotherapy, molecular targeted therapy, and immunotherapy, to provide reference information for current clinical treatment and future clinical research, and to better improve prognosis and quality of life in patients with hepatobiliary and pancreatic cancer.